DK2523960T3 - Heterocykliske carboxylsyrederivater med en 2,5-substitueret oxazolopyrimidinring - Google Patents

Heterocykliske carboxylsyrederivater med en 2,5-substitueret oxazolopyrimidinring

Info

Publication number
DK2523960T3
DK2523960T3 DK11700339.2T DK11700339T DK2523960T3 DK 2523960 T3 DK2523960 T3 DK 2523960T3 DK 11700339 T DK11700339 T DK 11700339T DK 2523960 T3 DK2523960 T3 DK 2523960T3
Authority
DK
Denmark
Prior art keywords
oxazolopyrimide
substituted
ring
carboxylic acid
acid derivatives
Prior art date
Application number
DK11700339.2T
Other languages
English (en)
Inventor
Dieter Kadereit
Matthias Schaefer
Stephanie Hachtel
Axel Dietrich
Thomas Huebschle
Katrin Hiss
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DK2523960T3 publication Critical patent/DK2523960T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK11700339.2T 2010-01-14 2011-01-12 Heterocykliske carboxylsyrederivater med en 2,5-substitueret oxazolopyrimidinring DK2523960T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305043 2010-01-14
PCT/EP2011/050302 WO2011086080A1 (de) 2010-01-14 2011-01-12 Heterocyclische carbonsäurederivate mit einem 2,5-substituierten oxazolopyrimidinring

Publications (1)

Publication Number Publication Date
DK2523960T3 true DK2523960T3 (da) 2014-01-20

Family

ID=41820700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11700339.2T DK2523960T3 (da) 2010-01-14 2011-01-12 Heterocykliske carboxylsyrederivater med en 2,5-substitueret oxazolopyrimidinring

Country Status (21)

Country Link
US (1) US8846690B2 (da)
EP (1) EP2523960B1 (da)
JP (1) JP5841068B2 (da)
KR (1) KR101759127B1 (da)
CN (1) CN102834399B (da)
AR (1) AR079884A1 (da)
AU (1) AU2011206616B2 (da)
BR (1) BR112012017447B1 (da)
CA (1) CA2804128C (da)
DK (1) DK2523960T3 (da)
ES (1) ES2437471T3 (da)
HK (1) HK1178886A1 (da)
IL (1) IL220718A (da)
MX (1) MX2012007836A (da)
MY (1) MY156476A (da)
PT (1) PT2523960E (da)
RU (1) RU2559896C2 (da)
SG (1) SG182474A1 (da)
TW (1) TWI482623B (da)
UY (1) UY33180A (da)
WO (1) WO2011086080A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY33176A (es) 2010-01-13 2011-08-31 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2, 5, 7.
TWI478929B (zh) 2010-01-13 2015-04-01 Sanofi Aventis 含2,5,7-經取代唑并嘧啶環之羧酸衍生物
KR101764607B1 (ko) 2010-01-14 2017-08-03 사노피 2,5-치환된 옥사졸로피리미딘 유도체
PT2523962E (pt) * 2010-01-14 2014-02-06 Sanofi Sa Derivados de ácidos carboxílicos com um anel oxazolopirimidina substituído em 2,5
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
JP4638410B2 (ja) * 2003-04-30 2011-02-23 ノバルティス アーゲー スフィンゴシン−1−ホスフェートレセプターモジュレーターとしての、アミノプロパノール誘導体
ATE537825T1 (de) * 2003-05-19 2012-01-15 Irm Llc Immunosuppressive verbindungen und zusammensetzungen
PE20050158A1 (es) * 2003-05-19 2005-05-12 Irm Llc Compuestos inmunosupresores y composiciones
CN101291908A (zh) * 2005-08-23 2008-10-22 Irm责任有限公司 免疫抑制剂化合物和组合物
AU2006317689B2 (en) 2005-11-23 2013-07-25 Epix Delaware, Inc. S1P receptor modulating compounds and use thereof
EP2364976B1 (en) * 2007-03-21 2014-10-08 EPIX Pharmaceuticals, Inc. S1P receptor modulating compounds and use thereof
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
CN102159582B (zh) * 2008-07-15 2014-05-07 赛诺菲-安万特 作为Edg-1受体激动剂的噁唑并嘧啶
UY33176A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2, 5, 7.
TWI478929B (zh) * 2010-01-13 2015-04-01 Sanofi Aventis 含2,5,7-經取代唑并嘧啶環之羧酸衍生物
UY33178A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
KR101764607B1 (ko) * 2010-01-14 2017-08-03 사노피 2,5-치환된 옥사졸로피리미딘 유도체
PT2523962E (pt) * 2010-01-14 2014-02-06 Sanofi Sa Derivados de ácidos carboxílicos com um anel oxazolopirimidina substituído em 2,5

Also Published As

Publication number Publication date
WO2011086080A1 (de) 2011-07-21
MX2012007836A (es) 2012-07-30
KR101759127B1 (ko) 2017-07-18
CA2804128A1 (en) 2011-07-21
RU2012134548A (ru) 2014-02-20
TWI482623B (zh) 2015-05-01
AU2011206616B2 (en) 2016-06-16
JP2013517242A (ja) 2013-05-16
IL220718A (en) 2015-02-26
US8846690B2 (en) 2014-09-30
CN102834399B (zh) 2015-04-22
UY33180A (es) 2011-08-31
CN102834399A (zh) 2012-12-19
BR112012017447B1 (pt) 2019-10-29
US20130072502A1 (en) 2013-03-21
CA2804128C (en) 2017-12-12
KR20120101731A (ko) 2012-09-14
MY156476A (en) 2016-02-26
EP2523960B1 (de) 2013-10-16
JP5841068B2 (ja) 2016-01-06
AR079884A1 (es) 2012-02-29
EP2523960A1 (de) 2012-11-21
ES2437471T3 (es) 2014-01-10
BR112012017447A2 (pt) 2016-04-19
PT2523960E (pt) 2013-12-09
AU2011206616A1 (en) 2012-08-02
SG182474A1 (en) 2012-08-30
RU2559896C2 (ru) 2015-08-20
HK1178886A1 (en) 2013-09-19
TW201134474A (en) 2011-10-16

Similar Documents

Publication Publication Date Title
CY2020004I1 (el) Eνωση διαμινο ετεροκυκλικου καρβοξαμιδιου
DK2540728T3 (da) Heterocyklisk forbindelse
ZA201206440B (en) [5,6]heterocyclic compound
HK1187606A1 (zh) 取代的 -稠合含氮雜環化合物及其用途
BR112013019509A2 (pt) derivados heterocíclicos
FI20096151A (fi) Menetelmä ja järjestely kotona olevan lemmikkieläimen kulkureitin seuraamiseksi
CU24162B1 (es) Derivados 5-aril-1,2,4-triazolona ligada a bisarilo sustituidos
ECSP12011999A (es) Derivados benzamida sustituidos
BR112013010643A2 (pt) compostos heterocíclicos
DK2427454T3 (da) Heterocykliske phenoxymethylforbindelser
BR112012010238A2 (pt) compostos heterocíclicos pesticidas
DK2523960T3 (da) Heterocykliske carboxylsyrederivater med en 2,5-substitueret oxazolopyrimidinring
BRPI1011744A2 (pt) composto antiviral heterocíclico.
DK2380892T3 (da) Imidazothiazolderivat med prolinringstruktur
HK1178885A1 (en) Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
DK2523958T3 (da) Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring
EP2583965A4 (en) HETEROCYCLIC RING CONNECTION
DK2325510T3 (da) Kobling med en ringformet koblingskrop
BRPI1011208A2 (pt) Derivados herbicidas do ácido tetrônico espiroheterocíclico
EP2632255A4 (en) HETEROCYCLIC DIAZENIUM DIOLATE DERIVATIVES
HK1178888A1 (en) Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
FR2957385B1 (fr) Tuyere a col orientable
DK2614333T3 (da) Følerstiftanordning
TH112738B (th) อนุพันธ์เฮทเทอโรไซคลิก
TH0901002819A (th) อนุพันธ์ 6-ซับสทิวเทด ฟีนอกซีโครมาน คาร์บอกซิลิก แอซิด